Morgan Stanley
VERA icon

Morgan Stanley’s Vera Therapeutics VERA Stock Holding History

Morgan Stanley’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120M Buy
2,799,459
+2,430,699
+659% +$90.6M 0.01% 1416
2026
Q1 		$14.8M Sell
368,760
-130,905
-26% -$5.64M ﹤0.01% 3224
2025
Q4 		$25.3M Buy
499,665
+225,142
+82% +$8M ﹤0.01% 2713
2025
Q3 		$7.98M Sell
274,523
-1,963,729
-88% -$45.4M ﹤0.01% 3744
2025
Q2 		$52.7M Buy
2,238,252
+1,797,563
+408% +$40.4M ﹤0.01% 1871
2025
Q1 		$10.6M Buy
440,689
+112,174
+34% +$3.6M ﹤0.01% 3281
2024
Q4 		$13.9M Sell
328,515
-12,561
-4% -$556K ﹤0.01% 3092
2024
Q3 		$15.1M Buy
341,076
+35,638
+12% +$1.35M ﹤0.01% 3080
2024
Q2 		$11.1M Sell
305,438
-1,231,352
-80% -$48.8M ﹤0.01% 3247
2024
Q1 		$66.3M Buy
1,536,790
+541,950
+54% +$19.3M 0.01% 1503
2023
Q4 		$15.3M Buy
994,840
+80,094
+9% +$1.02M ﹤0.01% 2948
2023
Q3 		$12.5M Sell
914,746
-53,299
-6% -$914K ﹤0.01% 2907
2023
Q2 		$15.5M Buy
968,045
+927,377
+2,280% +$8.38M ﹤0.01% 2730
2023
Q1 		$316K Buy
40,668
+25,115
+161% +$194K ﹤0.01% 5491
2022
Q4 		$301K Sell
15,553
-7,407
-32% -$134K ﹤0.01% 5493
2022
Q3 		$489K Buy
22,960
+19,495
+563% +$365K ﹤0.01% 5283
2022
Q2 		$47K Sell
3,465
-15,053
-81% -$263K ﹤0.01% 6644
2022
Q1 		$435K Sell
18,518
-8,173
-31% -$176K ﹤0.01% 5496
2021
Q4 		$714K Buy
26,691
+4,685
+21% +$104K ﹤0.01% 5321
2021
Q3 		$382K Buy
22,006
+20,222
+1,134% +$362K ﹤0.01% 5654
2021
Q2 		$24K Buy
+1,784
New +$27.7K ﹤0.01% 6947

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley's VERA Position: Q2 2026 in Review

Morgan Stanley increased its Vera Therapeutics (VERA) stake by 659% in Q2 2026, buying an estimated $90.6M and bringing the position to 2,799,459 shares worth $120M. The position accounts for 0.01% of the portfolio, ranked #1416.

Morgan Stanley first reported a position in VERA in Q2 2021 and has held it in 21 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Morgan Stanley held 2,799,459 shares of Vera Therapeutics worth $120M as of Q2 2026.
  • Morgan Stanley bought 2,430,699 Vera Therapeutics shares in Q2 2026, an estimated $90.6M.
  • Vera Therapeutics made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1416 holding.
  • Morgan Stanley first reported a position in Vera Therapeutics in Q2 2021 and has held it in 21 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.